Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-03-31 6:43 pm Purchase | 2026-03-27 | 13G | ARS PHARMACEUTICALS, INC SPRY | MILLENNIUM MANAGEMENT LLC | 5,916,030 6.000% | 524,590 (+9.73%) | Filing History |
| 2026-03-24 4:18 pm Purchase | 2026-03-17 | 13G | ARS PHARMACEUTICALS, INC SPRY | MILLENNIUM MANAGEMENT LLC | 5,391,440 5.400% | 5,391,440 (New Position) | Filing History |
| 2026-02-13 4:24 pm Purchase | 2025-12-31 | 13G | ARS PHARMACEUTICALS, INC SPRY | Rubric Capital Management LP | 6,200,000 6.270% | 6,200,000 (New Position) | Filing History |
| 2026-01-21 12:30 pm Purchase | 2025-12-31 | 13G | ARS PHARMACEUTICALS, INC SPRY | BlackRock Inc. BLK | 5,013,000 5.100% | 5,013,000 (New Position) | Filing History |
| 2025-10-01 9:19 pm Purchase | 2025-09-29 | 13D | ARS PHARMACEUTICALS, INC SPRY | RA CAPITAL MANAGEMENT LLC | 10,940,977 11.100% | 80,000 (+0.74%) | Filing History |
| 2025-08-01 6:06 pm Sale | 2025-07-30 | 13D | ARS PHARMACEUTICALS, INC SPRY | Flynn James E | 7,610,217 7.750% | -1,023,320 (-11.85%) | Filing History |
| 2025-07-22 7:38 pm Sale | 2025-07-18 | 13D | ARS PHARMACEUTICALS, INC SPRY | Flynn James E | 8,633,537 8.790% | -1,090,971 (-11.22%) | Filing History |
| 2025-07-02 08:24 am Sale | 2025-07-02 | 13D | ARS PHARMACEUTICALS, INC SPRY | Flynn James E | 9,724,508 9.900% | -790,149 (-7.51%) | Filing History |
| 2025-03-24 7:57 pm Sale | 2025-03-20 | 13D | ARS PHARMACEUTICALS, INC SPRY | Flynn James E | 10,514,657 10.720% | -563,270 (-5.08%) | Filing History |
| 2024-06-17 8:47 pm Sale | 2024-06-13 | 13D | ARS PHARMACEUTICALS, INC SPRY | Pratik Shah Living Trust dated June 15 2011 | 5,219,124 5.400% | -1,332,900 (-20.34%) | Filing History |
| 2024-06-11 7:18 pm Sale | 2024-06-04 | 13D | ARS PHARMACEUTICALS, INC SPRY | Pratik Shah Living Trust dated June 15 2011 | 6,552,024 6.800% | -3,604,180 (-35.49%) | Filing History |
| 2024-03-29 4:14 pm Purchase | 2024-03-27 | 13D | ARS PHARMACEUTICALS, INC SPRY | RA CAPITAL MANAGEMENT LLC | 10,860,977 11.300% | 1,401,299 (+14.81%) | Filing History |
| 2024-02-09 08:35 am Sale | 2024-02-08 | 13G | ARS PHARMACEUTICALS, INC SPRY | FMR LLC | 1,202,315 1.252% | -4,167,047 (-77.61%) | Filing History |
| 2023-09-25 4:30 pm Purchase | 2023-09-21 | 13D | ARS PHARMACEUTICALS, INC SPRY | RA CAPITAL MANAGEMENT LLC | 9,459,678 9.900% | 2,700,000 (+39.94%) | Filing History |
| 2023-09-01 4:15 pm Sale | 2023-08-29 | 13D | ARS PHARMACEUTICALS, INC SPRY | Bell Robert G. | 4,313,965 4.500% | -4,250,000 (-49.63%) | Filing History |
| 2023-08-31 5:25 pm Purchase | 2023-08-29 | 13D | ARS PHARMACEUTICALS, INC SPRY | RA CAPITAL MANAGEMENT LLC | 6,759,678 7.070% | 5,017,492 (+288.00%) | Filing History |
| 2023-02-14 4:35 pm Unchanged | 2022-12-31 | 13G | ARS PHARMACEUTICALS, INC SPRY | NEXTECH VI ONCOLOGY SCSP | 1,910,029 2.000% | 0 (Unchanged) | Filing History |
| 2023-02-13 4:32 pm Purchase | 2022-12-31 | 13G | ARS PHARMACEUTICALS, INC SPRY | K2 PRINCIPAL FUND L.P. | 2,045,348 2.200% | 138,730 (+7.28%) | Filing History |
| 2023-02-09 08:23 am Purchase | 2023-02-09 | 13G | ARS PHARMACEUTICALS, INC SPRY | FMR LLC | 5,369,362 5.726% | 1,615,625 (+43.04%) | Filing History |
| 2022-11-30 4:23 pm Sale | 2022-11-08 | 13D | ARS PHARMACEUTICALS, INC SPRY | ORBIMED ADVISORS LLC | 7,788,510 8.300% | -1 (-0.00%) | Filing History |